Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 14.91M
June 30, 2026 14.34M
March 31, 2026 13.50M
December 31, 2025 13.18M
September 30, 2025 13.20M
June 30, 2025 1.386M
March 31, 2025 0.494M
December 31, 2024 0.38M
September 30, 2024 -0.599M
June 30, 2024 10.60M
March 31, 2024 10.32M
December 31, 2023 9.565M
September 30, 2023 8.932M
June 30, 2023 7.992M
March 31, 2023 7.155M
December 31, 2022 5.946M
September 30, 2022 4.38M
June 30, 2022 3.725M
March 31, 2022 3.693M
Date Value
December 31, 2021 3.875M
September 30, 2021 4.249M
June 30, 2021 3.513M
March 31, 2021 2.358M
December 31, 2020 1.299M
September 30, 2020 1.472M
June 30, 2020 1.713M
March 31, 2020 1.782M
December 31, 2019 2.234M
September 30, 2019 2.473M
June 30, 2019 1.574M
March 31, 2019 2.798M
December 31, 2018 3.289M
September 30, 2018 3.317M
June 30, 2018 4.114M
March 31, 2018 3.053M
September 30, 2017 2.126M
June 30, 2017 1.073M
March 31, 2017 0.5155M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Agilent Technologies, Inc. 3.96B
Bio-Rad Laboratories, Inc. 1.353B
Bruker Corp. 1.685B
Danaher Corp. 15.07B
Harvard Bioscience, Inc. 48.50M